RecQ mediated genome instability 2 (<i>RMI2</i>): a potential prognostic and immunological biomarker for pan-cancers

Wei Wei; Xiaomei Ying; Liang Chen; Qingmei Sun; Xiaohuan Lu; Yang Xia; Rubin Xu; Zhechen Zhu; Dong Zhang; Qikai Tang; Li Li; Jiaheng Xie; Hongzhu Yu

doi:doi:10.18632/aging.204076

← Back

Research Paper Volume 14, Issue 9 pp 4107—4136

RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers

Figure 5. Correlation of RMI2 expression with ImmuneScore and StromalScore in various cancers. (A) Correlation of RMI2 expression with ImmuneScore and StromalScore in ACC. (B) Correlation of RMI2 expression with ImmuneScore and StromalScore in GBM. (C) Correlation of RMI2 expression with ImmuneScore and StromalScore in KIRP. (D) Correlation of RMI2 expression with ImmuneScore and StromalScore in LUSC. (E) Correlation of RMI2 expression with ImmuneScore and StromalScore in THYM. (F) Correlation of RMI2 expression with ImmuneScore and StromalScore in UCEC.